Claire Xu, MD, PhD
Cong (Claire) Xu is Senior Vice President, Head of R&D Center of Excellence since March 2026, previously serving as Senior Vice President, Clinical Development from April 2021 to February 2026. Dr. Xu leads clinical operations, regulatory affairs, clinical pharmacology, biomarker, medical safety, biometrics and program management. Dr. Xu joined our company in 2018 as U.S. Site Head, leading the establishment of our company’s Maryland office and led the growth of the clinical team. Previously, from 2013 to 2018, Dr. Xu held roles of increasing responsibility in early phase development and translational medicine at Otsuka Pharmaceutical Development & Commercialization, where she was responsible for designing and overseeing multiple phase 1 and phase 2 studies of different therapeutic areas, including hematology and oncology. Dr. Xu earned a Ph.D. in Clinical Pharmacology from Indiana University School of Medicine and a Bachelor of Medicine from Zhongshan School of Medicine, Sun Yat-sen University, China.